U.S. Markets open in 4 hrs 37 mins

Cepheid Slumps: CPHD Tumbles 9.3% in Session

Zacks Equity Research

Cepheid (CPHD) saw a big move last session, as the company’s shares fell by about 9% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading below the volatile price range of $47.5 to $49.95 in the past one-month time frame.

This slump shouldn’t be too much of a surprise to investors, as although this molecular diagnostics company has seen no negative revision in the past few weeks, its current year loss consensus has widened over the last 30 days. This suggests there may be more trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.

CPHD currently has a Zacks Rank #3 (Hold).

Some better-ranked stocks in the Medical Instruments industry include Masimo Corporation (MASI), Accuray Incorporated (ARAY), and Heartware International Inc. (HTWR). While Masimo sports a Zacks Rank #1 (Strong Buy), Accuray and Heartware International hold a Zacks Rank #2 (Buy).  

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

CEPHEID INC (CPHD): Free Stock Analysis Report

MASIMO CORP (MASI): Free Stock Analysis Report

ACCURAY (ARAY): Free Stock Analysis Report


Zacks Investment Research